NEW YORK (GenomeWeb News) – BG Medicine said in a document filed yesterday with the US Securities and Exchange Commission that it has laid off 12 of its 22 employees, or roughly 55 percent of its workforce.

The company said it took this step "in order to reduce its operating expenses and extend its cash runway in anticipation of the commercial launch of automated versions of [its] galectin-3 test," which it plans to launch in the US in 2015.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.